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Abstract
In 2000, the National Research Council (NRC), an arm of the National Academy of Sciences,
released a report entitled, "Toxicological Effects of Methylmercury." The overall conclusion of that
report was that, at levels of exposure in some fish- and marine mammal-consuming communities
(including those in the Faroe Islands and New Zealand), subtle but significant adverse effects on
neuropsychological development were occurring as a result of in utero exposure. Since the release
of that report, there has been continuing discussion of the public health relevance of current levels
of exposure to Methylmercury. Much of this discussion has been linked to the release of the most
recent longitudinal update of the Seychelles Island study. It has recently been posited that these
findings supercede those of the NRC committee, and that based on the Seychelles findings, there
is little or no risk of adverse neurodevelopmental effects at current levels of exposure. In this
commentary, members of the NRC committee address the conclusions from the NRC report in
light of the recent Seychelles data. We conclude that no evidence has emerged since the publication
of the NRC report that alters the findings of that report.
Introduction
In 2000, the National Research Council (NRC), an arm of
the National Academy of Sciences, released a report enti-
tled, "Toxicological Effects of Methylmercury [1]" That
NRC committee reviewed the existing literature on the
health effects associated with exposure to methylmercury
(MeHg), including relatively low-level exposure from cur-
rent levels of fish consumption, and assessed the dose-
response relationship based on available epidemiological
studies. The overall conclusion of that report was that, at
levels of exposure in some fish- and marine mammal-con-
suming communities (including those in the Faroe
Islands [2] and New Zealand [3]), subtle but significant
adverse effects on neuropsychological development were
occurring as a result of in utero exposure. Based on those
findings, the committee also concluded that "...the risk to
that population [the women who consume large amounts
of fish and seafood during pregnancy] is likely to be suffi-
cient to result in an increase in the number of children
who have to struggle to keep up in school". Since the
release of that report, there has been continuing discus-
sion of the public health relevance of current levels of
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exposure to MeHg. Much of this discussion has been
linked to the release of the most recent longitudinal
update of the Seychelles Island study by Gary Myers et al.
[4], which reports no significant adverse neurological
effects of in utero MeHg exposure at 9 years of age. It has
been posited by the authors of that study in a letter to The
Lancet [5], as well as in a commentary [6] and subsequent
letter [7] by Constantine G. Lyketsos published in The
Lancet, that these findings supercede those of the NRC
committee, and that based on the Seychelles findings,
there is little or no risk of adverse neurodevelopmental
effects at current levels of exposure. As members of the
NRC committee that wrote the 2000 report, we do not
agree with this view. We, therefore, wish to address some
of the key points raised by Drs. Myers and Lyketsos
Discussion
In his commentary, Lyketsos discounts the NRC report on
the grounds that the Committee did not have access to the
Seychelles 9-year follow-up data. However, at the time of
its deliberation, the committee knew that this follow-up
assessment was in progress and recognized that the con-
sistent negative effects from the earlier stages of the Sey-
chelles study made it highly unlikely that adverse effects
would emerge in the 9-year follow-up. The Committee's
conclusions, therefore, were based on an the considera-
tion that the consistent adverse effects reported in the
Faroe Islands and New Zealand studies would not be con-
firmed in this Seychelles cohort at any point in develop-
ment. Thus, in our opinion the continued absence of
negative effects in the most recent Seychelles data does not
alter the overall interpretation of the data or the conclu-
sions of the report.
In addition to assertions about how the new data from the
Seychelles should alter the current view of the public
health risk from methylmercury exposure, Lyketsos takes
the position in that "the Seychelles study is methodologi-
cally the most advanced" study conducted to date. The
basis for this assertion is unclear. From a research design
perspective, the Seychelles and Faroes studies were very
similar, and both were state-of-the-art. Both studies used
continuous measures of exposure based on reliable
biomarkers, statistical control for a broad range of poten-
tial confounders, and measurement of standard, well-
respected measures of neuropsychological function.
Although the 9-year Seychelles follow-up assessed a larger
number of developmental end points, adverse effects were
seen in the Faroes and New Zealand studies in multiple
domains of cognitive and neuromotor function.
The NRC report noted that there is a strong scientific con-
sensus that blood lead concentrations in excess of 10 µg/
dL place a child at increased risk for poor developmental
outcomes. Nevertheless, not all lead studies have found
this association, and substantial variability exists in the
magnitudes of the reported effects [8]. If two studies from
this literature were chosen randomly, it is likely that the
results would not be entirely concordant. A similar con-
sensus is emerging regarding the effects of low-level PCB
exposure on developmental outcomes despite some stud-
ies which failed to detect negative effects [9]. The uncer-
tainties inherent in conducting human studies, which, for
ethical reasons, must rely on statistical rather than experi-
mental control for confounders, stem, in part, from
unmeasured confounders and effect modifiers that may
be idiosyncratic to the sample being studied, but can
interfere with our ability to detect true effects and to rep-
licate those found in other studies.
Thus, the failure to detect adverse effects in the Seychelles
study could well be due to the substantial sample-to-sam-
ple variation expected when trying to identify relatively
subtle effects on development in an inherently "noisy"
system of complex, multi-determined neurobehavioral
end points. The NRC report also emphasized that study-
to-study comparisons are best made on the basis of the
estimated value of parameters of interest, not simply on
whether the studies yield "p < .05". In fact, the NRC anal-
ysis noted that comparing the studies with respect to their
estimated benchmark doses and associated confidence
limits noted much less discrepancy between them.
Myers et al., the authors of the Seychelles studies, argue in
their letter to The Lancet [5] that hair mercury concentra-
tion is the only methylmercury exposure marker which
has been correlated "against actual brain concentrations"
[10] and that cord blood mercury has not. It should be
noted that the correlation that Myers refers to is between
mercury in maternal hair and infant  brains. The same
study also examined the correlation between mercury in
infant blood and infant brains, and both sets of correla-
tions were in the same range (0.6–0.8 vs. 0.4–0.8, respec-
tively). Since cord blood is the gestational surrogate of
infant blood, the study cited by Myers et al. supports the
conclusions reached in the NRC report; namely, that the
use of either cord blood or maternal hair mercury is ade-
quate for estimating the exposure dose. Since these met-
rics each provide information about different periods of
development, use of both metrics will increase the likeli-
hood of uncovering a true dose-response relationship.
Both measures were, in fact, employed in the Faroes study
and gave strikingly similar results although the cord blood
measures generally yielded slightly stronger associations
(in terms of p-values).
An essential point, which Myers et al. appear to have mis-
construed, is that exposure misclassification (i.e., errors in
matching the exposure-based biomarker of dose to the
observed effect) generally makes it less likely to observe aEnvironmental Health: A Global Access Science Source 2004, 3 http://www.ehjournal.net/content/3/1/2
Page 3 of 4
(page number not for citation purposes)
true relationship and is highly unlikely to result in a spu-
rious relationship. Both cord blood and maternal hair
(and, in fact, all exposure measures) result in some degree
of exposure misclassification. Thus, any exposure metric
(including cord blood) which yields statistically valid
relationships across a range of developmental endpoints
provides useful information about the relationship
between dose and response.
Another point which continues to be raised in the discus-
sion of the applicability of the Faroes data to exposures in
other communities is the notion of "bolus doses" [7]. It is
important to point out that this notion is hypothetical
and is supported by few data. Because the largest source of
methylmercury exposure in the Faroese is consumption of
whale meat that is relatively high in methylmercury con-
centration, it has been suggested that whale meat dinners
might lead to isolated large spikes in methylmercury
exposure during pregnancy. Grandjean has pointed out
however, that in addition to whale dinners, stored (frozen
and dried) portions of whale meat are also consumed in
small amounts as snacks over extended periods of time
[11]. Dietary assessments in both the Faroes and Sey-
chelles studies were limited and the extent of "bolus"
doses cannot be readily determined in either study. How-
ever, Grandjean et al. [12] report that the mercury concen-
tration in the proximal 2 cm of pregnancy-period
maternal hair in the Faroes study correlated with the con-
centration in full-duration pregnancy period hair with a
coefficient of 0.93. This is comparable to the correlation
of 0.85–0.91 seen in a similar analysis in the Seychelles
using hair segments of about 3 cm [7] and suggests that
the influence of "bolus dose," if any, is comparable in the
two studies. Grandjean et al. [12] further report that the
individual children whose mother's hair showed the
greatest variability in mercury concentration between seg-
ment and full length did not influence the outcome of the
dose-response assessment, Lyketsos [7] appears to misun-
derstand the intent of such comparisons. These compari-
sons do not speak to the effect of variability in exposure
per se on developmental outcomes, but speaks directly to
the notion of bolus dose. The larger the bolus dose, the
greater the variability that is expected between the mer-
cury concentration in the segment and the full-length hair
sample, which reflects average exposure. Thus, "bolus
doses" in the Faroes cohort do not seem to be responsible
for the observed effects of methylmercury on develop-
ment.
Finally, issues have been raised as to the power of the var-
ious studies to detect an effect in developmental out-
comes. Lyketsos [7] claims that the Seychelles study had
power of 90% to detect neurodevelopmental effects of
mercury toxicity, challenging the NRC report, which esti-
mated that the Seychelles study had power of only 50% to
detect several of the effects seen in the Faroes study. Given
that the Faroe Islands and Seychelles studies had similar
ranges of exposure, power considerations are driven pri-
marily by sample size, so it stands to reason that the Sey-
chelles study (just under 800 mother/infant pairs) will
have less power than the Faroe study (over 1000 pairs).
While it may well be true that the Seychelles study was
designed with 90% power to detect a particular effect, it is
also true that the study had only around 50% power to
detect five of the eight effects seen in the Faroes (see Table
7-1 and Figure 7-2 of the NRC report).
Conclusions
In his letter, Lyketsos acknowledges that "it is beyond
doubt" that mercury is neurotoxic and that there may be a
need to warn pregnant women against eating certain sea-
food. [7] The key issue is the determination of the doses at
which methylmercury is neurotoxic. The Reference Dose
we recommended in the NRC report is derived from a
benchmark dose of 58 µg/l MeHg in blood. This corre-
sponds to the exposure level that doubles the risk of
adverse neurological development from 5% to 10% in the
Faroes cohort. This is an important potential public
health impact, which is preventable. In the interest of pro-
tecting public health, we believe it is better to err on the
side of caution in the face of three well-designed studies,
two of which are positive and one of which is negative. No
evidence that has emerged since the publication of the
NRC report changes our view on this issue. Once reason-
able evidence of adverse effects has been provided, the
issue is not whether methylmercury exposure from fish
can pose a risk, but rather the dose (including an appro-
priate margin of safety) that is appropriate to provide pru-
dent protection for the most vulnerable individuals in the
population.
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